REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioextra Zrt. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BIOEXTRA Zrt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Bioextra Zrt. is based in Hungary, with the head office in Budapest. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 01, 2009. There are currently 86 (2023) people employed by Bioextra Zrt.. From the latest financial highlights, Bioextra Zrt. reported a net sales revenue increase of 10.52% in 2022. Its’ total assets recorded a growth of 14.98%. Bioextra Zrt.’s net profit margin decreased by 0.83% in 2022.

Headquarters
Vaci ut 33.
Budapest; Budapest; Postal Code: 1134

Contact Details: Purchase the Bioextra Zrt. report to view the information.

Website: http://www.bioextra.hu

Basic Information
Total Employees:
Purchase the Bioextra Zrt. report to view the information.
Outstanding Shares:
Purchase the Bioextra Zrt. report to view the information.
Registered Capital:
Purchase the Bioextra Zrt. report to view the information.
Financial Auditors:
Purchase the Bioextra Zrt. report to view the information.
Incorporation Date:
April 01, 2009
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Recyclomed Nonprofit Kft.
Company Performance
Financial values in the chart are available after Bioextra Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.52%
Total operating revenue
10.48%
Operating profit (EBIT)
3.8%
EBITDA
8.39%
Net Profit (Loss) for the Period
5.2%
Total assets
14.98%
Total equity
16.18%
Operating Profit Margin (ROS)
-1.09%
Net Profit Margin
-0.83%
Return on Equity (ROE)
-3.26%
Debt to Equity Ratio
-5.08%
Quick Ratio
-0.35%
Cash Ratio
-0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?